Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-091813
Filing Date
2021-03-24
Accepted
2021-03-24 06:13:16
Documents
3
Period of Report
2021-03-24

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d115736d6k.htm 6-K 304842
2 GRAPHIC g115736g74m35.jpg GRAPHIC 2156
3 GRAPHIC g115736g99w66.jpg GRAPHIC 2936
  Complete submission text file 0001193125-21-091813.txt   313217
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 21766506
SIC: 2834 Pharmaceutical Preparations